Balyasny Asset Management
EXAS

Balyasny Asset Management’s Exact Sciences EXAS Stock Holding History

Balyasny Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,089,977
Closed -$415M – 3071
2025
Q4 		$415M Buy
4,089,977
+3,242,412
+383% +$260M 0.53% 26
2025
Q3 		$46.4M Buy
847,565
+732,425
+636% +$36.6M 0.06% 386
2025
Q2 		$6.12M Buy
+115,140
New +$5.85M 0.01% 1187
2025
Q1 		– Sell
-593,319
Closed -$33.3M – 2927
2024
Q4 		$33.3M Buy
+593,319
New +$36.9M 0.05% 458
2024
Q3 		– Sell
-325,668
Closed -$18.4M – 2863
2024
Q2 		$13.8M Sell
325,668
-435,177
-57% -$23.9M 0.02% 754
2024
Q1 		$52.5M Buy
760,845
+754,323
+11,566% +$47.7M 0.09% 288
2023
Q4 		$482K Sell
6,522
-821
-11% -$53.8K ﹤0.01% 1963
2023
Q3 		$501K Sell
7,343
-225,587
-97% -$19.1M ﹤0.01% 1759
2023
Q2 		$21.9M Buy
232,930
+147,954
+174% +$11.5M 0.05% 492
2023
Q1 		$5.76M Sell
84,976
-1,081,433
-93% -$69.5M 0.01% 1018
2022
Q4 		$57.7M Buy
+1,166,409
New +$47.7M 0.16% 157
2022
Q3 		– Sell
-32,730
Closed -$1.35M – 2955
2022
Q2 		$1.29M Buy
+32,730
New +$1.75M ﹤0.01% 1646
2021
Q4 		– Sell
-5,809
Closed -$513K – 2343
2021
Q3 		$554K Buy
+5,809
New +$613K ﹤0.01% 1461
2021
Q2 		– Sell
-257,195
Closed -$33.9M – 2074
2021
Q1 		$33.9M Buy
+257,195
New +$35.2M 0.17% 144
2020
Q3 		– Sell
-37,687
Closed -$3.28M – 1382
2020
Q2 		$3.28M Buy
+37,687
New +$3.01M 0.03% 612
2018
Q2 		– Sell
-10,427
Closed -$421K – 1869
2018
Q1 		$421K Sell
10,427
-1,273
-11% -$62.1K ﹤0.01% 1502
2017
Q4 		$615K Sell
11,700
-2,700
-19% -$144K ﹤0.01% 1487
2017
Q3 		$679K Buy
14,400
+5,700
+66% +$229K ﹤0.01% 1259
2017
Q2 		$308K Sell
8,700
-5,500
-39% -$170K ﹤0.01% 1304
2017
Q1 		$335K Buy
+14,200
New +$281K ﹤0.01% 1380
2016
Q4 		– Sell
-587,576
Closed -$10.9M – 1392
2016
Q3 		$10.9M Sell
587,576
-247,424
-30% -$4.36M 0.06% 372
2016
Q2 		$10.2M Buy
+835,000
New +$6.29M 0.07% 347
2016
Q1 		– Sell
-265,650
Closed -$2.45M – 1343
2015
Q4 		$2.45M Buy
+265,650
New +$2.47M 0.02% 624

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Balyasny Asset Management's EXAS Position: Q1 2026 in Review

Balyasny Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,089,977 shares — an estimated $415M sold.

Balyasny Asset Management first reported a position in EXAS in Q4 2015 and held it in 23 quarters. The position peaked at $415M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Balyasny Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 4,089,977 Exact Sciences shares in Q1 2026, an estimated $415M.
  • Balyasny Asset Management first reported a position in Exact Sciences in Q4 2015 and held it in 23 quarters.
  • Balyasny Asset Management's Exact Sciences position peaked at $415M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.